Have a symptom?
See what questions
a doctor would ask.
News » Last resort leukemia drug receives FDA approval

Last resort leukemia drug receives FDA approval

The FDA has approved Clolar (clofarabine) Intravenous Infusion for treatment of children aged 1 to 21 who have failed at least two previous cancer treatments for acute lymphocytic leukemia.

Source: summary of medical news story as reported by CBS Market Watch

Related Disease Topics:

Article Source Details

About: Last resort leukemia drug receives FDA approval

Date: 29 December 2004

Source: CBS Market Watch


Related Medical Topics

This summary article refers to the following medical categories:

  • Cancer
  • Medication
  • Medication and cancer
  • Medication and acute lymphocytic leukemia

More News Topics

  • New drug for Crohn’s disease sufferers
  • New drug prevents vision loss
  • New drug promises asthma cure
  • New drug provides hope for mesothelioma sufferers
  • New drug proving effective in reducing cancer cells following chemotherapy
  • New drug receives approval for use against only one type of cancer
  • New drug strategy for asthmatics
  • New drug treatment for Wilson's disease show's promise
  • New dual therapy for cancer treatment
  • New Ephedra alternative aimed to promote weight loss
  • New eye disease detection equipment receives FDA approval
  • New eye test may be able to correctly diagnose ADHD
  • New fast anthrax test approved by the FDA

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise